Kwong, Jeffrey C.

Living near major roads and the incidence of dementia, Parkinson's disease, and multiple sclerosis: a population-based cohort study

Chen, H., Kwong, J. C., Copes, R., Tu, K., Villeneuve, P. J., van Donkelaar, A., Hystad, P., Martin, R. V., Murray, B. J., Jessiman, B., et al. (2017) · The Lancet

Air Quality and Health ImpactsNoise Effects and Management

Cited by 776

Exposure to ambient air pollution and the incidence of dementia: a population-based cohort study

Chen, H., Kwong, J. C., Copes, R., Hystad, P., van Donkelaar, A., Tu, K., Brook, J. R., Goldberg, M. S., Martin, R. V., Murray, B. J., et al. (2017) · Environment International

Air Quality and Health ImpactsDementia and Cognitive Impairment Research

Cited by 394

Estimated Effectiveness of COVID-19 Vaccines Against Omicron or Delta Symptomatic Infection and Severe Outcomes

Buchan, S. A., Chung, H., Brown, K. A., Austin, P. C., Fell, D. B., Gubbay, J. B., Nasreen, S., Schwartz, K. L., Sundaram, M. E., Tadrous, M., et al. (2022) · JAMA Network Open

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 356

Effectiveness of COVID-19 vaccines against Omicron or Delta symptomatic infection and severe outcomes

Buchan, S. A., Chung, H., Brown, K. A., Austin, P. C., Fell, D. B., Gubbay, J. B., Nasreen, S., Schwartz, K. L., Sundaram, M. E., Tadrous, M., et al. (2022) · JAMA Network Open

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 356

Effectiveness of BNT162b2 and mRNA-1273 covid-19 vaccines against symptomatic SARS-CoV-2 infection and severe covid-19 outcomes in Ontario, Canada: test negative design study

Chung, H., He, S., Nasreen, S., Sundaram, M. E., Buchan, S. A., Wilson, S. E., Chen, B., Calzavara, A., Fell, D. B., Austin, P. C., et al. (2021) · BMJ

SARS-CoV-2 and COVID-19 ResearchVaccine Coverage and Hesitancy

Cited by 307

COVID-19 vaccines and adverse events of special interest: A multinational Global Vaccine Data Network (GVDN) cohort study of 99 million vaccinated individuals

Faksova, K., Walsh, D., Jiang, Y., Griffin, J., Phillips, A., Gentile, A., Kwong, J. C., Macartney, K., Naus, M., Grange, Z., et al. (2024) · Vaccine

SARS-CoV-2 and COVID-19 ResearchPharmacovigilance and Adverse Drug Reactions

Cited by 212

Epidemiology of myocarditis and pericarditis following mRNA vaccination by vaccine product, schedule, and interdose interval among adolescents and adults in Ontario, Canada

Buchan, S. A., Seo, C. Y., Johnson, C., Alley, S., Kwong, J. C., Nasreen, S., Calzavara, A., Lu, D., Harris, T. M., Yu, K., et al. (2022) · JAMA Network Open

Viral Infections and Immunology ResearchSARS-CoV-2 and COVID-19 Research

Cited by 157

Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study

Sundaram, M. E., Calzavara, A., Mishra, S., Kustra, R., Chan, A. K., Hamilton, M. A., Djebli, M., Rosella, L. C., Watson, T., Chen, H., et al. (2021) · Canadian Medical Association Journal

COVID-19 epidemiological studiesSARS-CoV-2 detection and testing

Cited by 118

Risk of Guillain-Barre syndrome after seasonal influenza vaccination and influenza health-care encounters: a self-controlled study.

Kwong, J. C., Vasa, P. P., Campitelli, M. A., Hawken, S., Wilson, K., Rosella, L. C., Stukel, T. A., Crowcroft, N. S., McGeer, A. J., Zinman, L., et al. (2013) · The Lancet Infectious Diseases

Peripheral Neuropathies and DisordersInfluenza Virus Research Studies

Cited by 115

A disproportionate epidemic: COVID-19 cases and deaths among essential workers in Toronto, Canada

Rao, A., Ma, H., Moloney, G., Kwong, J. C., Jüni, P., Sander, B., Kustra, R., Baral, S. D., & Mishra, S. (2021) · Annals of Epidemiology

COVID-19 epidemiological studiesHealthcare Systems and Challenges

Cited by 60

Effectiveness of mRNA COVID-19 vaccine booster doses against Omicron severe outcomes

Grewal, R., Nguyen, L., Buchan, S. A., Wilson, S. E., Nasreen, S., Austin, P. C., Brown, K. A., Fell, D. B., Gubbay, J., Schwartz, K. L., et al. (2022) · Nature Communications

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 59

Increasing concentration of COVID-19 by socioeconomic determinants and geography in Toronto, Canada: an observational study

Mishra, S., Ma, H., Moloney, G., Yiu, K. C. Y., Darvin, D., Landsman, D., Kwong, J. C., Calzavara, A., Straus, S., Chan, A. K., et al. (2022) · Annals of Epidemiology

COVID-19 epidemiological studiesPublic Health and Social Inequalities

Cited by 53

Evaluation of Coseasonality of Influenza and Invasive Pneumococcal Disease: Results from Prospective Surveillance

Kuster, S. P., Tuite, A. R., Kwong, J. C., McGeer, A., the Toronto Invasive Bacterial Diseases Network, & Fisman, D. N. (2011) · PLoS Medicine

Pneumonia and Respiratory InfectionsInfluenza Virus Research Studies

Cited by 52

Barriers to the use of reminder/recall interventions for immunizations: a systematic review

the Public Health Agency of Canada/Canadian Institutes of Health Research Influenza Research Network (PCIRN) Vaccine Coverage Theme Group, Pereira, J. A., Quach, S., Heidebrecht, C. L., Quan, S. D., Kolbe, F., Finkelstein, M., & Kwong, J. C. (2012) · BMC Medical Informatics and Decision Making

Vaccine Coverage and HesitancyElectronic Health Records Systems

Cited by 50

Understanding heterogeneity to inform the public health response to COVID-19 in Canada

Mishra, S., Kwong, J. C., Chan, A. K., & Baral, S. D. (2020) · Canadian Medical Association Journal

COVID-19 epidemiological studiesSARS-CoV-2 and COVID-19 Research

Cited by 50

Assessing COVID-19 vaccine effectiveness against Omicron subvariants: Report from a meeting of the World Health Organization

Feikin, D. R., Higdon, M. M., Andrews, N., Collie, S., Deloria Knoll, M., Kwong, J. C., Link-Gelles, R., Pilishvili, T., & Patel, M. K. (2023) · Vaccine

SARS-CoV-2 and COVID-19 ResearchCOVID-19 epidemiological studies

Cited by 36

Differential Patterns by Area-Level Social Determinants of Health in Coronavirus Disease 2019 (COVID-19)–Related Mortality and Non–COVID-19 Mortality: A Population-Based Study of 11.8 Million People in Ontario, Canada

Wang, L., Calzavara, A., Baral, S., Smylie, J., Chan, A. K., Sander, B., Austin, P. C., Kwong, J. C., & Mishra, S. (2023) · Clinical Infectious Diseases

COVID-19 epidemiological studiesHealth disparities and outcomes

Cited by 29

Social inequalities in COVID-19 death by area-level income in 11.2 million people in Ontario, Canada: patterns over time and the mediating role of vaccination.

Wang, L., Swayze, S., Bodner, K., Calzavara, A., Harrigan, S. P., Siddiqi, A., Baral, S. D., Austin, P. C., Smylie, J., Koh, M., et al. (2026) · American Journal of Epidemiology

COVID-19 epidemiological studiesVaccine Coverage and Hesitancy

Cited by 5